Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Inhibrx Biosciences (INBX) Long-Term Debt Issuances (2025)

Inhibrx Biosciences (INBX) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $100.0 million as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to $100.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $100.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $100.0 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q1 2025 was $100.0 million at Inhibrx Biosciences.
  • The five-year high for Long-Term Debt Issuances was $100.0 million in Q1 2025, with the low at $100.0 million in Q1 2025.